Galapagos to supply chemical compound sets to Johnson & Johnson Pharmaceutical Research & Development
09 Mar 2007 -
Galapagos NV announced that its service division, BioFocus DPI, has entered into an agreement to supply small molecule compounds for drug discovery to the Johnson & Johnson Pharmaceutical Research & Development Division of Janssen Pharmaceutica NV (J&JPRD). Under the terms of the two-year agreement, BioFocus DPI will provide access to compounds from its SoftFocus small molecule libraries and will
also generate customer specific compound library sets for use in J&JPRD's drug discovery programs. Financial terms were not disclosed.
Top
Contact
Print version
PDF version
Send article
RSS-Feed
